IQVIA is the gold standard for proprietary commercial claims (~300M+ lives), NRx/TRx prescribing data, and real-world evidence studies. Medistill covers the public-data side: 25M+ adverse-event reports, 1.12M plan formulary mappings, drug safety signals, provider compliance across 130+ sources, and 10M+ court cases, all at from $199/mo.
Their strength
Proprietary claims + NRx/TRx
Our strength
Safety, compliance, formulary
What we add
adverse-event data + court cases + 130+ sources
| Feature | | IQVIA |
|---|---|---|
| Core approach | Pharma intelligence layer, safety signals, formulary coverage, compliance screening, provider intelligence, court case research | Proprietary real-world data platform, commercial claims, prescribing analytics, RWE studies, consulting |
| Commercial claims | Not available | ~300M+ lives of proprietary commercial claims, gold standard for payer and prescribing analytics |
| adverse-events | 25M+ FDA adverse event reports with signal detection, drug–event pairs, seriousness flags | adverse-event reporting access via analytics platform; proprietary RWE augments signal detection |
| Clinical trials | 577K trials (clinical-trial registry) with status, phase, sponsor, enrollment data | Clinical trial data integrated in RWE platform; proprietary investigator-level data |
| plan formulary coverage | 1.12M drug–plan formulary mappings: tier, prior auth, step therapy, quantity limits | Formulary data available as add-on; primarily focused on commercial claims |
| Prescribing data (NRx/TRx) | prescribing data by NPI, volume, cost, beneficiary counts per drug | Industry-standard NRx/TRx data from retail pharmacy networks (~300M prescriptions/wk) |
| Industry payments (pharma spend) | Every industry payment to every provider by company, product, and year | Not a primary focus; available via external data linkage in some products |
| Drug safety / recalls | FDA drug enforcement actions, recall classifications, market withdrawals, MedWatch signals | Safety data integrated in broader pharmacovigilance analytics; not a standalone public feed |
| Provider compliance screening | 130+ enforcement sources: OIG, SAM, 50 state boards, FDA debarment, NPDB, CMS penalties, court records | Not a core offering, compliance screening is outside IQVIA’s primary scope |
| Court cases | 10M+ cases with full opinion text, citation lookup, malpractice and drug litigation history | Not available |
| Hospital financials | CMS cost reports, Medicare utilization, quality scores across 6K+ hospitals | Hospital analytics available via IQVIA Hospital Intelligence product |
| Device intelligence | 510(k) clearances, PMA approvals, MAUDE device adverse events, recall actions | Medical device analytics available as separate product line |
| Real-world evidence (RWE) | Public RWE via linked adverse-event reporting, claims proxies, and trial data, not proprietary patient-level data | Flagship strength, longitudinal patient-level RWE studies, outcomes research, regulatory submissions |
| Claims-based analytics | Medicare claims patterns via plan-level and provider utilization data (public) | Deep multi-payer claims analytics including commercial, Medicare Advantage, Medicaid managed care |
| Market access / payer analytics | Formulary tier positioning, prior auth burden, step therapy across all plans | Full market access suite: formulary analytics, payer mix, pull-through measurement |
| Interface | Ask in any language, get answers in any language. Works on desktop and mobile. Generate custom reports, share with anyone, schedule recurring analyses. API for automation. | Enterprise portal + analyst support + professional services for custom studies |
| Deployment | Self-serve, instant access, no contract | Enterprise contracts, implementation timelines, dedicated account teams |
| Pricing | from $199/mo unlimited queries | $100K–$1M+/yr depending on products and data licenses |
Use IQVIA if:
You need proprietary commercial claims (~300M+ lives), industry-standard NRx/TRx prescribing data from retail pharmacy networks, longitudinal patient-level real-world evidence studies, or regulatory-grade RWE for FDA submissions. IQVIA's proprietary data assets are irreplaceable for commercial launch analytics, market access, and outcomes research.
Use Medistill if:
You need adverse-event signal detection (25M+ reports), plan formulary coverage analysis (1.12M mappings), drug safety and recall monitoring, provider compliance screening across 130+ enforcement sources, industry-payment conflict-of-interest checks, or drug litigation research across 10M+ court cases, at from $199/mo with no contract.
Use both if:
Keep IQVIA for proprietary commercial claims and NRx/TRx prescribing analytics where no public substitute exists. Add Medistill for drug safety surveillance , formulary intelligence (plan-level), provider compliance screening (130+ sources), and court case research, capabilities IQVIA does not cover, at from $199/mo alongside your existing IQVIA contract.
Pricing
Pro $199 / 500 credits · Business $499 / 1,500 credits · Unlimited $999 ($9,990/yr) · Team from $599/seat
Full access to all 2,000+ datasets. No per-query fees. 1 credit per entity processed.
No credit card required. Expires in 15 days.